Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with ...

The FDA said risks linked to CAR-T cell therapies can be effectively communicated through existing labeling, including boxed ...

Boston: TOBY, Inc., a biotech startup advancing non-invasive cancer detection through urine-based volatilomics and Artificial ...

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

Restricted availability under an FDA-mandated drug safety program has limited the reach of CAR-T cell therapies for certain ...

ABBV-706 is an ADC targeting SEZ6 developed by AbbVie. It is linked to a topoisomerase 1 inhibitor (TOP1i) via a ...

A new medication found to reduce the chance of the most common types of breast cancer recurring will be available to many ...

Sigvotatug Vedotin is an ADC that targets integrin αvβ6-positive tumor cells. It has an engineered antibody that ensures high ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

A potentially life-saving treatment for early-stage breast cancer will become much more affordable for hundreds of ...

Karen Knudsen is leading Sean Parker’s cancer immunotherapy incubator where philanthropy and venture capital meet.